Kommentar
Once-daily roflumilast foam for treating scalp and body psoriasis
British Journal of Dermatology · 2023
DOI: 10.1093/bjd/ljad297 ↗Kurz gefasst
Kommentar in der Zeitschrift British Journal of Dermatology, 2023. Hauptthemen laut MEDLINE: Scalp, Psoriasis, Phosphodiesterase 4 Inhibitors.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
ScalpPsoriasisPhosphodiesterase 4 InhibitorsHumansAminopyridinesBenzamidesCyclopropanes
Substanzen
Phosphodiesterase 4 InhibitorsRoflumilastAminopyridinesBenzamidesCyclopropanes
Zitieren
APA
(2023). Once-daily roflumilast foam for treating scalp and body psoriasis. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad297
Vancouver
Once-daily roflumilast foam for treating scalp and body psoriasis. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad297
BibTeX
@article{euvimed2023,
title = {Once-daily roflumilast foam for treating scalp and body psoriasis},
journal = {British Journal of Dermatology},
year = {2023},
doi = {10.1093/bjd/ljad297}
}
EUVIMED